Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (KCT0012728) titled 'Development and 8-Week Pilot Testing of a Conversational AI App Providing Treatment Side Effect Information for Patients With Breast Cancer' on Oct. 1.
Study Type: Interventional Study
Study Design:
Primary Purpose : Supportive Care, Intervention Model : Single Group, Blinding/Masking : Open, Allocation : Not Applicable
Primary Sponsor: Daejeon University
Condition:
Neoplasms
Intervention:
Behavioral, Others(Digital health intervention (side effect information and self-management education delivered via a conversational AI-based mobile application)) : [Intervention name] Conversational artificial intelligence (A...